Guidance helps clinical trial subjects understand informed consent
Important trial information would be prominent and in plain language
Important trial information would be prominent and in plain language
Results showed under-reporting among certain populations
Report summarizes recommendations from drug development community
Setting and implementing standards are key to identification
Publication details drug approval efforts, scientific research and more
One eligible proposal accepted per quarter; submissions due by March 31
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.